Knott David M Jr Portfolio Stock Holdings
According to the SEC 13F filed on August 12, 2026, Knott David M Jr disclosed 81 stock positions valued at approximately $189.18M as of quarter-end June 30, 2026. The largest holdings include Alphabet Inc-Cl C, Apollo Global Management, Inc., and Syndax Pharmaceutical, Inc..
- Report Period
- June 30, 2026
- No. of Stocks
- 81
- Portfolio Value
- $189.18M
Holdings by Sector
Knott David M Jr Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| Alphabet Inc-Cl C | GOOG | Communication Services | 17.07% | 91,420 | - | - | $32,301,429 |
| Apollo Global Management, Inc. | APO | Financial Services | 14.07% | 225,000 | - | - | $26,619,750 |
| Syndax Pharmaceutical, Inc. | SNDX | Healthcare | 5.05% | 437,245 | +15,245 | +3.61% | $9,558,176 |
| Xeris Biopharma Holdings, Inc. | XERS | Healthcare | 4.44% | 1,060,000 | - | - | $8,395,200 |
| Travere Therapeutics, Inc. | TVTX | Healthcare | 4.42% | 147,282 | +6,649 | +4.73% | $8,367,090 |
| Protagonist Therapeutics, Inc | PTGX | Healthcare | 4.08% | 63,000 | - | - | $7,722,540 |
| Bridgebio Pharma, Inc. | BBIO | Healthcare | 3.66% | 92,850 | +2,850 | +3.17% | $6,915,468 |
| Iovance Biotherapeutics, Inc. | IOVA | Healthcare | 3.52% | 1,600,000 | - | - | $6,656,000 |
| Alkermes PLC | ALKS | Healthcare | 3.37% | 121,759 | +1,759 | +1.47% | $6,379,563 |
| JPMorgan Chase & Co. | JPM | Financial Services | 3.13% | 18,098 | -1,379 | -7.08% | $5,924,018 |
| Janus Henderson AAA CLO ETF | JAAA | Other | 2.50% | 93,528 | - | - | $4,722,229 |
| Cogent Biosciences Inc. | COGT | Healthcare | 2.27% | 111,081 | +7,081 | +6.81% | $4,298,835 |
| TG Therapeutics, Inc. | TGTX | Healthcare | 1.94% | 66,839 | -23,162 | -25.74% | $3,672,135 |
| Catalyst Pharmaceuticals, Inc. | CLST | Financial Services | 1.89% | 114,000 | +114,000 | +100.00% | $3,583,020 |
| Agios Pharmaceutical, Inc. | AGIO | Healthcare | 1.86% | 95,058 | +2,000 | +2.15% | $3,527,602 |
| Viridian Therapeutics, Inc. | VRDN | Healthcare | 1.76% | 181,000 | - | - | $3,324,970 |
| Relmada Therapeutics, Inc. | RLMD | Healthcare | 1.65% | 451,000 | +11,700 | +2.66% | $3,120,920 |
| Arcus Biosciences, Inc. | RCUS | Healthcare | 1.32% | 81,241 | - | - | $2,504,660 |
| Cybin Inc | HELP | Other | 1.29% | 370,000 | +20,000 | +5.71% | $2,445,700 |
| SPDR S&P Biotech ETF | XBI | Other | 1.25% | 15,000 | - | - | $2,373,750 |
| Rezolute, Inc. | RZLT | Healthcare | 1.02% | 370,000 | - | - | $1,924,000 |
| AllianceBernstein Holding L.P. | AB | Financial Services | 0.89% | 48,000 | - | - | $1,690,560 |
| Madrigal Pharmaaceuticals, Inc. | MDGL | Healthcare | 0.85% | 3,000 | +1,000 | +50.00% | $1,610,850 |
| AtriCure, Inc. | ATRC | Healthcare | 0.76% | 51,400 | - | - | $1,438,172 |
| DocGo, Inc. | DCGO | Healthcare | 0.73% | 2,670,850 | - | - | $1,378,426 |
| Ardelyx, Inc. | ARDX | Healthcare | 0.71% | 263,168 | +56,168 | +27.13% | $1,342,157 |
| Ultragenyx Pharmaceutical Inc. | RARE | Healthcare | 0.67% | 38,069 | +5,000 | +15.12% | $1,271,124 |
| The Panagram BBB-B CLO ETF | CLOZ | Other | 0.67% | 47,807 | - | - | $1,263,061 |
| Cullinan Therapeutics, Inc. | CGEM | Healthcare | 0.67% | 69,182 | +44,982 | +185.88% | $1,259,804 |
| Johnson & Johnson | JNJ | Healthcare | 0.66% | 4,922 | - | - | $1,250,041 |
Showing 30 of 81 holdings in the latest reporting period.